CG Oncology, Inc. Common stock beat EPS estimates 0% of the time across 1 reported quarters (0 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q12026 FY2026 | $-0.58 | $-0.71 | -22.4% | Miss |
Back to CGON overview · CGON holders · CGON KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.